Cargando…
The Nanosystems Involved in Treating Lung Cancer
Even though there are various types of cancer, this pathology as a whole is considered the principal cause of death worldwide. Lung cancer is known as a heterogeneous condition, and it is apparent that genome modification presents a significant role in the occurrence of this disorder. There are conv...
Autores principales: | Crintea, Andreea, Dutu, Alina Gabriela, Samasca, Gabriel, Florian, Ioan Alexandru, Lupan, Iulia, Craciun, Alexandra Marioara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307574/ https://www.ncbi.nlm.nih.gov/pubmed/34357054 http://dx.doi.org/10.3390/life11070682 |
Ejemplares similares
-
The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2022) -
Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2022) -
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation
por: Crintea, Andreea, et al.
Publicado: (2022) -
Nanotechnology Involved in Treating Urinary Tract Infections: An Overview
por: Crintea, Andreea, et al.
Publicado: (2023) -
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview
por: Crintea, Andreea, et al.
Publicado: (2023)